You are on page 1of 15

ICORE CONNECT INC (VMCI

)

http://www.otcmarkets.com/stock/VMCI/profile

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001408057&owner=include
>Recent Recapitalization and current filing under correct CIK.

>CIK Reflects Past & Current Name Changes

>Share Structure and Name have yet to be updated on OTC Markets Site since they were VEMICS Inc. and is
showing Delinquent Pink No Information

>Company has been contacted and has verified that they have plans in near future to become current
ICORE CONNECT INC (VMCI)

http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=kry5w%252fYtlHnTh4djP052jw%253d%253d&nt7=0

Company Contact – Via Company Website https://www.icoreconnect.com/investor-contact

Phone 888-810-7706

Company Website: https://www.icoreconnect.com/

Twitter: https://twitter.com/icoreconnect?lang=en

Facebook: https://www.facebook.com/iMedicor/
ICORE CONNECT INC (VMCI)

VMCI Investors Hangout Board is Dead – No Mods and No Posts Since 2014 -
https://investorshangout.com/Vemics-Inc-VMCI-68297/#35634

VMCI Ihub Board is not very active at all - https://investorshub.advfn.com/Vemics-Inc-VMCI-8577/

Consistent with name change Vemics Inc. Site no longer works: http://www.vemics.com

IMedicor site redirects you to iCoreConnect site as it should: http://www.imedicor.com/

iCoreConnect creates software that allows anyone to share information at the highest levels of security, backed
by highly-engaged customer support. The company is a national provider of secure, HIPAA-compliant
communications and cloud-based practice management. iCoreConnect allows doctors, patients and other
healthcare providers to easily communicate with 2048-bit encryption and collaborate with the assurance they
are in full compliance with all current federal laws. All iCoreConnect healthcare industry applications meet the
federal government’s five technical safeguards for HIPAA-compliant communication.

The iCoreConnect product line includes:
ICORE CONNECT INC (VMCI)

Although we have no financials to go by currently, Example of iCoreConnect Pricing on one of their products
when it is discounted via the company website:

This is per subscriber, they request practice name and number of subscriptions:

State associations who have chosen iCoreExchange as their preferred HIPAA-compliant email vendor:

 Colorado Dental Association

 Florida Dental Association Crown Savings

 Georgia Dental Association

 Louisiana Dental Association

 New York State Dental Association

 South Carolina Dental Association

 Texas Dental Association Perks Program

 Virginia Dental Association
ICORE CONNECT INC (VMCI)

 New York State Dental Association

Official Georgia Dental Association Site Listing under Practice Services:
http://www.gadental.org/practiceservices/icoreconnect

Official New York State Dental Association listed under NYSDA Endorsed Vendors:
https://www.nysdental.org/nysda-membership/endorsed-vendors

Official Colorado Dental Association Endorsement: http://cdaonline.org/news/latest-news/cda-endorsed-
products-spotlight-imedicor/
ICORE CONNECT INC (VMCI)

Official Florida Dental Association Crown Savings Affiliate: http://www.fdaservices.com/affiliate/icoreexchange/

Official Louisiana Dental Association Endorsed Provider:
http://www.ladental.org/component/content/archive/2014/7

Official South Carolina Dental Association Endorsed for email encryption: http://www.scda.org/icoreconnect

Official Texas Dental Association Perks Program Endorsed: http://tdaperks.com/programs/hipaa-compliant-email/
ICORE CONNECT INC (VMCI)

Official Virginia Dental Association reference as a VDA endorsed vendor:
http://www.vadental.org/home/2017/08/02/ada-ce-online-maintaining-your-sanity-and-practice-viability-as-a-
medicaid-provider-embracing-program-integrity

Huge News - ICoreConnect Selected to Join StartUp Health Moonshot Academy & Global Army of Health
Transformers

http://www.nbc-2.com/story/36626036/icoreconnect-selected-to-join-startup-health-moonshot-academy-global-
army-of-health-transformers

Following a rigorous selection process, iCoreConnect today announces it has been accepted into StartUp Health
Moonshot Academy and is joining its global army of Health Transformers.

"iCoreConnect's technology changes the way patients and doctors communicate with one another by giving them
the freedom to exchange sensitive health information with ease, in full HIPAA compliance," said iCoreConnect
President and CEO Robert McDermott.

"Partnering with StartUp Health gives us the opportunity to further expand our reach, improving patient
experiences and outcomes not only in the U.S. but internationally as well."

Who is StartUp Health? https://www.startuphealth.com/ StartUp Health has assembled the world’s largest
community of Health Transformers and built a worldwide network of over 30,000 innovators, industry leaders, and
investors committed to supporting the entrepreneurs reimagining health and wellness.
ICORE CONNECT INC (VMCI)

Requirements iCore Connect had to meet to be in the Moonshot Academy:
https://www.startuphealth.com/marketing/academy

>>>>>YOU HAVE 12-18 MONTHS OF CAPITAL >>>> REVENUE, USER TRACTION, GROWING EXPONENTIALLY

Requirements iCore Connect had to meet to be A Moonshot Partner:
https://www.startuphealth.com/marketing/academy
ICORE CONNECT INC (VMCI)

Start Up Health Team and Board of Directors and Investors:
https://www.startuphealth.com/marketing/army/board

StartUp Health's long-term platform for entrepreneurs includes the StartUp Health Academy, StartUp Health
Network, StartUp Health Media and StartUp Health Ventures. Icore Connect is now a Moonshot Partner.

Founded by Steven Krein and Unity Stoakes, StartUp Health is chaired by former Time Warner CEO Jerry Levin.
Notable strategic partners and investors include AARP; Aurora Health Care; California Health Care Foundation;
Steve Case; Mark Cuban; Esther Dyson; Brad Feld; Genentech; GE Ventures; Janssen Research &
Development; Kaiser Permanente Ventures; Robert Wood Johnson Foundation; SAP; and SeventySix Capital.

TRANSFORMATION THIS YEAR WITH RECAPITALIZATION

On March 30, 2017, stockholders of iCore Connect Inc., formerly known as iMedicor, Inc., holding Series A
Preferred Stock, Series B Preferred Stock, Common Stock, and holders of convertible debt of the Company entered
into a Recapitalization Agreement dated as of November 1, 2016 (the "Recapitalization Agreement") for the
purpose of recapitalizing the Company (the "Recapitalization").

The Board of Directors designated June 30, 2017 as the Recapitalization Date and written notice thereof was given
to all of the parties to the Recapitalization Agreement.

First the holders of the Convertible Debt converted all of the Convertible Debt (consisting of approximately
$6,482,325 aggregate principal amount of indebtedness) at a price per share of $0.001 into approximately
6,482,325,000 shares of Common Stock. (This will equal out to 3,705,642 shares if they held through the split with
a 1.75 avg. if price per share was also split adjusted)

Immediately following the conversion of the Convertible Debt into shares of Common Stock, the Company
converted the Series B Preferred Stock and immediately after the Series A Preferred Stock into shares of Common
Stock. The purpose of these conversions was to simplify the capitalization of the Company and eliminate the
potential dilution that the outstanding shares of Series B Preferred Stock and Series A Preferred Stock represented
ICORE CONNECT INC (VMCI)

which the Company believed depressed the value of the Common Stock and restricted the ability of the Company
to raise funds to conduct its operations and to add value to the Company and its Common Stock.

Immediately following the conversion of the Convertible Debt, the Series B Preferred Stock, and the Series A
Preferred Stock, the Company combined its outstanding shares of Common Stock by a ratio of 1: 1,749.3119
shares of Common Stock, as determined by the Company’s Board of Directors, so that immediately following such
reverse split the number of outstanding shares of Common Stock would be 10,000,000 shares.

The Articles of Incorporation were amended and restated in their entirety. Following the filing of the Reverse Split
Amendment, the Company is authorized to issue six hundred ten million (610,000,000) shares, consisting of six
hundred million (600,000,000) shares of Common Stock, of which, approximately ten million (10,000,000) shares
were outstanding, and ten million (10,000,000) shares of Preferred Stock, none of which were outstanding. The
Recapitalization was effective upon the filing of the Reverse Split Amendment.

After the Recapitalization, the Company further amended and restated its Articles of Incorporation to change the
name of the Company from iMedicor, Inc. to iCoreConnect Inc.

Immediately following the Recapitalization, the Company had issued and sold to investors Series A Bridge Notes in
the aggregate principal amount of $6,251,544 and Series A Bridge Warrants exercisable to purchase 6,251,544
shares of Common Stock.

Bridge Notes were converted pursuant to such Conversion Agreements on June 30, 2017 immediately following
the Recapitalization into 17,502,623 shares of Common Stock of the Company at a price equal to $0.45 per share.

Series A Bridge Notes in the aggregate principal amount of $38,654 were not converted and continue to be
outstanding and bear interest at the rate of 18% per annum. These Series A Bridge Notes (principal and accrued
and unpaid interest) are convertible into shares of Common Stock at a price equal to $0.45 per share.

Investors who purchased Series A Bridge Notes also received one Series A Bridge Warrant for every $1.00 in
principal amount of Series A Bridge Notes purchased in the Series A Bridge Offering. Each Series A Bridge Warrant
is exercisable until December 31, 2019 to purchase one share of Common Stock at an exercise price equal to $1.35
per share (the “Series A Bridge Warrant Exercise Price”),

The Series A Bridge Warrants are callable by the Company if there exists a public trading market for the shares of
Common Stock, there is an effective registration statement registering for resale under the Securities Act of 1933,
and the closing price of the Common Stock on an exchange registered with the SEC has equaled at least 150% of
the then current Series A Bridge Warrant Exercise Price for 20 of the preceding 30 trading days and the volume for
such 30 trading days has averaged 50,000 shares per day (for example, if the Series A Bridge Warrant Exercise Price
is $1.35 the Series A Bridge Warrants are callable if the Common Stock closes above $2.02 per share for 20 of the
preceding 30 trading days with the average volume in excess of 50,000 shares per day for such 30 trading days.

The Company had issued and sold to investors Series B Bridge Notes in the aggregate principal amount of $295,811
and Series B Bridge Warrants exercisable to purchase 295,811 shares of Common Stock. The Company pursuant to
the terms of the Series B Bridge Notes converted on June 30, 2017 immediately following the Recapitalization all of
the outstanding Series B Bridge Notes into 657,308 shares of Common Stock of the Company at a price equal to
$0.45 per share of Common Stock.

Investors who purchased Series B Bridge Notes also received one Series B Bridge Warrant for every $1.00 in
principal amount of Series B Bridge Notes purchased in the Series B Bridge Offering. Each Series B Bridge Warrant
is exercisable until December 31, 2019 to purchase one share of Common Stock at an exercise price equal to $1.35
per share. The warrants are callable by the company under the same criteria as the series A warrants.

AFTER RECAPITALIZATION - Authorized but unissued – 590,000,000
ICORE CONNECT INC (VMCI)

AFTER CONVERSION OF BRIDGE NOTES - Authorized but unissued - 571,840,623

Stock Reserved for Issuance After Recapitalization - 25,046,846 + Stock Reserved For Issuance After Conversion
Of Bridge Notes 7,003,119 = 32,049,965

There are also some stock options in filings since they went by IMedicor https://www.sec.gov/cgi-bin/own-
disp?action=getissuer&CIK=0001408057 that have not been updated that expire in 2019 ranging from .003-.006.
No Confirmation that they have all been sold, exercised, or split adjusted so I did not take these into account.

https://www.sec.gov/Archives/edgar/data/1408057/000165495417006062/vmci_8k.htm

Company Press Releases

https://www.newswire.com/news/icoreconnect-selected-to-join-startup-health-moonshot-academy-global-
20007651

https://www.newswire.com/news/new-york-state-dental-association-endorses-icoreexchange-hipaa-19936051
ICORE CONNECT INC (VMCI)

http://www.news9.com/story/36249696/samuel-b-fortenbaugh-iii-named-to-icoreconnect-board-of-directors

http://vaticanbreakingnews.com/stories/icoreconnect-donates-practice-management-software-to-texas-non-
profit~71031/

http://www.news12.com/story/36023172/fda-services-crown-savings-chooses-icoredental-practice-management
ICORE CONNECT INC (VMCI)

http://walesbreakingnews.com/stories/imedicor-inc-becomes-icoreconnect-inc~rwA/

https://www.newswire.com/news/imedicor-inc-announces-consumation-of-recapitalization-19639217

https://www.icoreconnect.com/single-post/2017/06/16/iMedicor-Inc-Announces-Resignation-of-Donald-Sproat-
and-Appointment-of-Scott-Malmanger-as-Chief-Financial-Officer-and-Chief-Accounting-Officer
ICORE CONNECT INC (VMCI)

https://www.prnewswire.com/news-releases/imedicor-signs-relationship-with-florence-darlington-technical-
college-270323281.html

https://www.prnewswire.com/news-releases/imedicor-launches-proprietary-icoremd-cloud-based-customizable-
electronic-health-records-platform-269381751.html

https://www.prnewswire.com/news-releases/imedicor-launches-proprietary-icoredental-cloud-based-
customizable-electronic-health-records-platform-269986261.html
ICORE CONNECT INC (VMCI)